In a Nutshell
We are a United States-based and globally-sponsored venture capital fund that invests in high potential technologies at the series A and B financing stages in order to hold significant minority stakes in a diversified group of disruptive companies.
We are the Swanlaab’s first establishment in the United States and are backed up by an Israeli venture capital group, Giza Venture Capital (Giza VC) and Swanlaab Spain. With more than 25 years of investing experience, they have made more than 120 investments and achieved more than 40 successful exits. Since 1992, Swanlaab and Giza have managed six funds and invested over $650 million.
Thanks to its expertise and experienced team, Giza Venture Capital Group has become one of the leading VC groups and has led to numerous successful exits. Some of the winning investments include: XtremIO (acquired by EMC for $435M), Soluto (acquired by Asurion for $100M+), Oplus (acquired by Intel for $100M+), Actimize (acquired by NICE Systems for $281M), Precise (IPO on NASDAQ; acquired by Veritas), Zoran (IPO on NASDAQ; acquired by CSR), M-Systems (IPO on NASDAQ; acquired by SanDisk).
Innovation and Technology
We invest in globally competitive startups who have strong innovations in their technologies, that provide high barriers to entry, and are focused on B2B business models. Our H3IT (healthcare, information technology, Internet, and impact investment) strategy is clear and sets us apart in the market.
All in all, Swanlaab USA has everything for smart investors to maximize shareholder value.
– great pedigree, history, and background
– business model ready for long term value acceleration
– sustainable competitive advantages for multiple bottom lines